These findings highlight that co-expression of PRLR along with polarity proteins positively promotes patient survival outcomes within the wider breast cancer population emphasizing the essential and clinical relevance of contribution of PRL/PRLR pathway in driving a positive prognostic value of A/B polarity proteins on breast cancer patient outcome. The gene discussed is PRL; the disease is breast cancer.